Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Coverage varies widely by plan and by diagnosis
After subcutaneous administration, tirzepatide binds to both GIP and GLP-1 receptors on pancreatic beta cells, enhancing insulin secretion in a glucose-dependent manner while simultaneously suppressing glucagon release when blood glucose levels are elevated
Foundayo targets patients that injectables cannot easily reach: the needle-averse, the schedule-constrained, and patients priced out of branded pens
Complete Endorsements: Our items are joined by exhaustive testaments,including FDA-Salis,HALAL,ISO,CCRE5,organicUSDA,natural,and EUOrganic confirmations,certifying their quality and consistence with global principles
US$ 25.51
US$ 29.74
US$ 21.81
